Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop (Q44953022)

7 December 2017

title

Mantle cell lymphoma: report of the 2009 Mantle Cell Lymphoma Consortium Workshop (English)

1 reference

7 December 2017

0 references

1 reference

Oliver W Press

6

0 references

Owen A. O'Connor

5

object named as

Owen A O'Connor

1 reference

7 December 2017

7

Wyndham H Wilson

1 reference

7 December 2017

Michael E Williams

1

1 reference

7 December 2017

Martin H Dreyling

2

1 reference

7 December 2017

Brad S Kahl

3

1 reference

7 December 2017

John P Leonard

4

1 reference

7 December 2017

language of work or name

1 reference

1 March 2010

1 reference

7 December 2017

1 reference

7 December 2017

volume

51

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

390-398

1 reference

MicroRNA expression profiles classify human cancers

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Patterns of microRNA expression characterize stages of human B-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Cyclin D1 activation in B-cell malignancy: association with changes in histone acetylation, DNA methylation, and RNA polymerase II binding to both promoter and distal sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

A loss-of-function RNA interference screen for molecular targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Inhibition of p97-dependent protein degradation by Eeyarestatin I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

High level of glutathione-S-transferase pi expression in mantle cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903503453

10.3109/10428190903503453

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference